Finalist
Wobble Genomics: From Stealth to Spotlight
by M+F Health on behalf of Wobble Genomics
Summary of work
Wobble Genomics, an innovative healthcare and biotechnology company at the forefront of long-read RNA sequencing, had been working in stealth mode to build an exciting and potentially revolutionary pillar for the next generation of medicine.
Driven by a passion to revolutionise the fields of diagnosis and treatment, Wobble knew that to share their latest promising data with the scientific community, and to allow their technology to reach its full potential, there was a critical business need to emerge from stealth.
M+F Health recognised this was a rare and pivotal opportunity for Wobble Genomics to make an impact amongst target audiences. By implementing a carefully curated strategy ground in credibility, trust, and transparency, the agency worked at speed to shine a spotlight on Wobble’s scientific leadership. We surpassed our targets to showcase Wobble as not just another player in the field, but as a pioneering force that has the potential to redefine the future of RNA sequencing and analysis.
Judges’ comments
“Wobble Genomics” had a strong targeted approach, really understanding the stakeholders. It had excellent results with a relatively modest budget and the judges though it was thoughtfully considered and interesting. It established scientific credibility and demonstrated the power of communications done well.
